NCT05761093Completed
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 350 (actual)
- First submitted
- 28 Feb 2023
- Start date
- 7 Sept 2022
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Prostate cancer
- NCT number
- NCT05761093
What you commit to
- Study type: Observational
- Participants enrolled: 350
- From 7 Sept 2022 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- if patients are unable to complete the survey by themselves due to physical or psychological reasons,
- deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons,
- deemed ineligible by treating physicians
Who the study is looking for
- aged 18 years or older,
- diagnosis of metastatic prostate cancer within 5 years,
- able to read and write,
- accepting and signing the informed consent
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital Coordinator of this site? Confirm its status | Shatin | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.